KBP5074-2-001

Brief Summary:

This is a Phase 2 randomized, double-blind, placebo-controlled, multi-center study to assess the efficacy, safety, and pharmacokinetics of KBP-5074 in patients with moderate-to-severe chronic kidney disease and uncontrolled hypertension.

View The Poster For This Study

View The Letter To The Patients Of This Study

View More Information On This Study

 

 

INTERESTED IN THIS STUDY?  CLICK HERE TO CONTACT US.